Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
39.08
+1.40 (3.72%)
Nov 10, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Upgrades $79.00 → $93.00 | Buy | Upgrades | $79.00 → $93.00 | +137.97% | Sep 16, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $108.89 | Buy | Maintains | $108.89 | +178.63% | Sep 11, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $83.34 | Buy | Maintains | $83.34 | +113.25% | Sep 4, 2026 |
| CMB International Securities | CMB International Securities | Buy Reiterates $100.50 | Buy | Reiterates | $100.50 | +157.16% | Sep 3, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +176.36% | Jul 13, 2026 |